Stocks
Mutual Funds
ETFs
Pro Tools
Terminal
WealthView
Pricing
Learn More
stocks539561-BOM
resources
539561-BOM

Supha Pharmachem Ltd.

BSE: 539561
Sector: Services
0.35+0.0 (+2.94%)
24 Jul, 12:00 AM

Annual Reports and Financial Documents

Supha Pharmachem Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.
2013201420152016201720182019202020212022202320242025
Annual ReportsFY 2013FY 2014FY 2015FY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
Quarterly Results————————————
Conference Calls—————————————
Presentations—————————————

Corporate Announcements and Regulatory Filings

Supha Pharmachem Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.
  • General30 Jun 2026
    Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 Regarding The Order Passed By Hon'Ble National Company Law Appellate Tribunal (NCLAT) Principal Bench, New Delhi
    Disclosure under Regulation 30 of SEBI (LODR), 2015
  • Closure of Trading Window27 Jun 2026
    Closure of Trading Window
    Intimation for closure of Trading Window
  • General12 May 2026
    Intimation Of Change In Insolvency Professional - Appointment Of Resolution Professional (RP) In Place Of Interim Resolution Professional (IRP)
    Appointment of Resolution Professional in place of Interim Resolution Professional
  • General17 Apr 2026
    Post- Coc Update
    Disclosure to take note of decisions taken in 1st COC meeting held on 14.04.2026
  • List of Creditors 10 Apr 2026
    Corporate Insolvency Resolution Process (CIRP)-List of Creditors
    This disclosure is to place on record List of Creditors as required to be placed under Reg 13(2)(c) of IBBI CIRP Regulations
  • General2 Apr 2026
    Postponement Of Board Meeting Under Regulation 30 Of SEBI (LODR) Regulations, 2015
    Update on CIRP Proceedings, Non-Cooperation by Directors (Power suspended) and Postponement of Board Meeting under Regulation 30 of SEBI (LODR) Regulation, 2015
  • Closure of Trading Window25 Mar 2026
    Closure of Trading Window
    Closure of Trading window
  • General21 Mar 2026
    Intimation Of Receipt Of Order From National Company Law Tribunal (NCLT)
    Intimation of receipt of Order from National Company Law Tribunal (NCLT)
  • General20 Mar 2026
    Submission Of Form A - PUBLIC ANNOUNCEMENT
    Submission of Form A - PUBLIC ANNOUNCEMENT
  • Appointment of Interim Resolution Professional (IRP)19 Mar 2026
    Announcement under Regulation 30 (LODR)-Appointment of Interim Resolution Professional (IRP)
    Intimation for Admission of Co. under CIRP and appointment of IRP
  • General17 Mar 2026
    Intimation Of Change In Registered Office
    Intimation of change in registered office of the company to office no. F81D, Express Zone Mall, A wing Next to Patel Vanika, W.E. Highway, Goregaon, (East), Mumbai - 400063, w.e.f. 17th ....
  • Board Meeting Rescheduled9 Mar 2026
    Board Meeting Intimation for To Consider Un-Audited Financial Results/Statements (Standalone & Consolidated) Of The Company For The Third Quarter And Nine Months Ended December, 31, 2025 And Update On Trading Window
    Supha Pharmachem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/03/2026 ,inter alia, to consider and approve To consider Un-Audited Financial ....
  • Board Meeting Rescheduled25 Feb 2026
    Board Meeting Intimation for Rescheduled Of Board Meeting On 09.03.2026
    Supha Pharmachem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/03/2026 ,inter alia, to consider and approve unaudited standalone and consolidated ....
  • Board Meeting Rescheduled17 Feb 2026
    Board Meeting Intimation for Rescheduled Of Board Meeting On 25.02.2026
    Supha Pharmachem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/02/2026 ,inter alia, to consider and approve unaudited standalone and consolidated ....
  • General14 Feb 2026
    Intimation Of Postponement And Rescheduling Of Board Meeting Under Regulation 29 Of SEBI (LODR) Regulations, 2015
    Rescheduling on 25/02/2026
  • Demise14 Feb 2026
    Announcement under Regulation 30 (LODR)-Demise
    Demise of CS and Compliance Officer
  • Board Meeting3 Feb 2026
    Board Meeting Intimation for Consider Un-Audited Financial Results/Statements (Standalone & Consolidated) Of The Company For The Third Quarter And Nine Months Ended December, 31, 2025
    Supha Pharmachem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2026 ,inter alia, to consider and approve Un-Audited Financial Results/Statements ....
  • Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 201820 Jan 2026
    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
    Submission of Reg. 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended 31.12.2025
  • Closure of Trading Window22 Dec 2025
    Closure of Trading Window
    Intimation of closure of Trading Window
  • Change of Name15 Dec 2025
    Announcement under Regulation 30 (LODR)-Change of Company Name
    Company is pleased to informed that MCA has approved the change of name vide certificate of incorporation W.E.F. 15/12/2025 from REMEDIUM LIFECARE LTD. TO SUPHA PHARMACHEM LIMITED

Frequently Asked Questions

Where can I download the annual report of Supha Pharmachem Ltd.?
Annual reports of Supha Pharmachem Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.
Where can I find the quarterly results of Supha Pharmachem Ltd.?
Quarterly earnings results and presentations of Supha Pharmachem Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.
Does Supha Pharmachem Ltd. publish earnings call transcripts?
Earnings call transcripts of Supha Pharmachem Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.
Where can I find investor presentations of Supha Pharmachem Ltd.?
Investor presentations and annual day presentations of Supha Pharmachem Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.
What are the recent corporate announcements of Supha Pharmachem Ltd.?
Corporate announcements and regulatory filings of Supha Pharmachem Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.
How do I access the regulatory filings of Supha Pharmachem Ltd.?
Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of Supha Pharmachem Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.
What is the ISIN of Supha Pharmachem Ltd.?
The ISIN (International Securities Identification Number) of Supha Pharmachem Ltd. is INE549S01036. This is the unique identifier used across exchanges and depositories.
On which stock exchange is Supha Pharmachem Ltd. listed?
Supha Pharmachem Ltd. is listed on NSE and BSE. The NSE symbol is 539561-BOM and the BSE code is -.
Where can I find the shareholding pattern of Supha Pharmachem Ltd.?
The quarterly shareholding pattern of Supha Pharmachem Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.
How current is the data for Supha Pharmachem Ltd. on Sharpely?
Share price data for Supha Pharmachem Ltd. is updated as of 24 Jul 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.